Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndrome type 2 should avoid Ozempic due to the potential risks of thyroid tumors observed in animal studies
Key Takeaways BPC-157 is a Promising Peptide for Lyme Disease: Renowned for its regenerative and anti-inflammatory properties, BPC-157 offers potential benefits for those battling Lyme disease and co-infections by promoting tissue repair, reducing inflammation, and supporting immune function
Following the success of the SELECT trial, Wegovy (semaglutide in doses of 1.7 mg and 2.4 mg) received a similar approval in March 2024 for people with overweight or obesity and cardiovascular disease
A major goal for Breakthrough T1D is to advance AID systems that do not require meal announcements to improve both glucose outcomes and quality of life for people with T1D
For instance, Mounjaro may be covered by Medicare and Medicaid when prescribed for Type 2 diabetes
Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease
